ReNetX Bio
PrivateLast Round
Series A
Extension
Sep 30, 2020
Total Funding Raised
$1M
Company Overview
ReNetX Bio is a biotechnology company that develops first-in-class therapeutics to treat injuries and damage to the central nervous system, including spinal cord injury, stroke, and glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReNetX Bio Comparables
Compare ReNetX Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioAxone BioSciences | 82% | |
| Neuroplast | 82% | |
| NervGen Pharma Corp. | 81% |
ReNetX Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 30, 2020 | ||||
| Series A | May 8, 2018 | ||||
| Convertible Debt | Jul 10, 2014 | ||||
| Corporate Funding | May 1, 2012 |
ReNetX Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Convertible Debt, Series A Extension, Series A |
| Wings for Life Foundation | Series A |
| Spring Mountain Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2014
Raised $1M with Connecticut Innovations participating.
- May 1, 2012
AstraZeneca participated in the round.
ReNetX Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ReNetX Bio's valuation, stock price, and market status.
Is ReNetX Bio a public or private company?
ReNetX Bio is a private company.
What is the current stock price of ReNetX Bio?
ReNetX Bio is a private company with no public stock price. No recent secondary market data is available.
How much is ReNetX Bio worth (valuation)?
Valuation information for ReNetX Bio is not publicly available.
Can I buy ReNetX Bio stock?
ReNetX Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ReNetX Bio's last funding round?
ReNetX Bio's most recent funding round was Series A Extension on September 30, 2020.
Who are the main investors in ReNetX Bio?
Key investors in ReNetX Bio include Connecticut Innovations, Spring Mountain Capital.
Will ReNetX Bio IPO soon?
No public IPO plans have been announced for ReNetX Bio.
How can I track ReNetX Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ReNetX Bio's secondary market activity and sign up for updates.